Global COVID-19 Diagnostic Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 42487
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The COVID-19 Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global COVID-19 Diagnostic Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global COVID-19 Diagnostic Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

COVID-19 Diagnostic Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Nucleic Acid Testing

Antibody Testing

Market segment by Application, can be divided into

Hospitals

Scientific Research

Market segment by players, this report covers

Cellex

Abbott

Roche

BioMedomics

BD

Henry Schein

Safecare Bio-Tech

Mayo Clinic Laboratories

Chembio Diagnostics

Mount Sinai Laboratory

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Innovita Biological Technology

Guangzhou Wondfo Biotech

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

ADVAITE

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of COVID-19 Diagnostic Testing

1.2 Classification of COVID-19 Diagnostic Testing by Type

1.2.1 Overview: Global COVID-19 Diagnostic Testing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global COVID-19 Diagnostic Testing Revenue Market Share by Type in 2020

1.2.3 Nucleic Acid Testing

1.2.4 Antibody Testing

1.3 Global COVID-19 Diagnostic Testing Market by Application

1.3.1 Overview: Global COVID-19 Diagnostic Testing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Scientific Research

1.4 Global COVID-19 Diagnostic Testing Market Size & Forecast

1.5 Global COVID-19 Diagnostic Testing Market Size and Forecast by Region

1.5.1 Global COVID-19 Diagnostic Testing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global COVID-19 Diagnostic Testing Market Size by Region, (2016-2021)

1.5.3 North America COVID-19 Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.4 Europe COVID-19 Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific COVID-19 Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.6 South America COVID-19 Diagnostic Testing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa COVID-19 Diagnostic Testing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 COVID-19 Diagnostic Testing Market Drivers

1.6.2 COVID-19 Diagnostic Testing Market Restraints

1.6.3 COVID-19 Diagnostic Testing Trends Analysis

2 Company Profiles

2.1 Cellex

2.1.1 Cellex Details

2.1.2 Cellex Major Business

2.1.3 Cellex COVID-19 Diagnostic Testing Product and Solutions

2.1.4 Cellex COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Cellex Recent Developments and Future Plans

2.2 Abbott

2.2.1 Abbott Details

2.2.2 Abbott Major Business

2.2.3 Abbott COVID-19 Diagnostic Testing Product and Solutions

2.2.4 Abbott COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Recent Developments and Future Plans

2.3 Roche

2.3.1 Roche Details

2.3.2 Roche Major Business

2.3.3 Roche COVID-19 Diagnostic Testing Product and Solutions

2.3.4 Roche COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Roche Recent Developments and Future Plans

2.4 BioMedomics

2.4.1 BioMedomics Details

2.4.2 BioMedomics Major Business

2.4.3 BioMedomics COVID-19 Diagnostic Testing Product and Solutions

2.4.4 BioMedomics COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 BioMedomics Recent Developments and Future Plans

2.5 BD

2.5.1 BD Details

2.5.2 BD Major Business

2.5.3 BD COVID-19 Diagnostic Testing Product and Solutions

2.5.4 BD COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 BD Recent Developments and Future Plans

2.6 Henry Schein

2.6.1 Henry Schein Details

2.6.2 Henry Schein Major Business

2.6.3 Henry Schein COVID-19 Diagnostic Testing Product and Solutions

2.6.4 Henry Schein COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Henry Schein Recent Developments and Future Plans

2.7 Safecare Bio-Tech

2.7.1 Safecare Bio-Tech Details

2.7.2 Safecare Bio-Tech Major Business

2.7.3 Safecare Bio-Tech COVID-19 Diagnostic Testing Product and Solutions

2.7.4 Safecare Bio-Tech COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Safecare Bio-Tech Recent Developments and Future Plans

2.8 Mayo Clinic Laboratories

2.8.1 Mayo Clinic Laboratories Details

2.8.2 Mayo Clinic Laboratories Major Business

2.8.3 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Product and Solutions

2.8.4 Mayo Clinic Laboratories COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Mayo Clinic Laboratories Recent Developments and Future Plans

2.9 Chembio Diagnostics

2.9.1 Chembio Diagnostics Details

2.9.2 Chembio Diagnostics Major Business

2.9.3 Chembio Diagnostics COVID-19 Diagnostic Testing Product and Solutions

2.9.4 Chembio Diagnostics COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Chembio Diagnostics Recent Developments and Future Plans

2.10 Mount Sinai Laboratory

2.10.1 Mount Sinai Laboratory Details

2.10.2 Mount Sinai Laboratory Major Business

2.10.3 Mount Sinai Laboratory COVID-19 Diagnostic Testing Product and Solutions

2.10.4 Mount Sinai Laboratory COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Mount Sinai Laboratory Recent Developments and Future Plans

2.11 Ortho Clinical Diagnostics

2.11.1 Ortho Clinical Diagnostics Details

2.11.2 Ortho Clinical Diagnostics Major Business

2.11.3 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Product and Solutions

2.11.4 Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Ortho Clinical Diagnostics Recent Developments and Future Plans

2.12 Zhejiang Orient Gene Biotech

2.12.1 Zhejiang Orient Gene Biotech Details

2.12.2 Zhejiang Orient Gene Biotech Major Business

2.12.3 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Product and Solutions

2.12.4 Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Zhejiang Orient Gene Biotech Recent Developments and Future Plans

2.13 Innovita Biological Technology

2.13.1 Innovita Biological Technology Details

2.13.2 Innovita Biological Technology Major Business

2.13.3 Innovita Biological Technology COVID-19 Diagnostic Testing Product and Solutions

2.13.4 Innovita Biological Technology COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Innovita Biological Technology Recent Developments and Future Plans

2.14 Guangzhou Wondfo Biotech

2.14.1 Guangzhou Wondfo Biotech Details

2.14.2 Guangzhou Wondfo Biotech Major Business

2.14.3 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Product and Solutions

2.14.4 Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Guangzhou Wondfo Biotech Recent Developments and Future Plans

2.15 Guangdong Hecin-Scientific

2.15.1 Guangdong Hecin-Scientific Details

2.15.2 Guangdong Hecin-Scientific Major Business

2.15.3 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Product and Solutions

2.15.4 Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Guangdong Hecin-Scientific Recent Developments and Future Plans

2.16 Dynamiker Biotechnology (Tianjin)

2.16.1 Dynamiker Biotechnology (Tianjin) Details

2.16.2 Dynamiker Biotechnology (Tianjin) Major Business

2.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Product and Solutions

2.16.4 Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans

2.17 ADVAITE

2.17.1 ADVAITE Details

2.17.2 ADVAITE Major Business

2.17.3 ADVAITE COVID-19 Diagnostic Testing Product and Solutions

2.17.4 ADVAITE COVID-19 Diagnostic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 ADVAITE Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global COVID-19 Diagnostic Testing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 COVID-19 Diagnostic Testing Players Market Share

3.2.2 Top 10 COVID-19 Diagnostic Testing Players Market Share

3.2.3 Market Competition Trend

3.3 COVID-19 Diagnostic Testing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global COVID-19 Diagnostic Testing Revenue and Market Share by Type (2016-2021)

4.2 Global COVID-19 Diagnostic Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global COVID-19 Diagnostic Testing Revenue Market Share by Application (2016-2021)

5.2 COVID-19 Diagnostic Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America COVID-19 Diagnostic Testing Revenue by Type (2016-2026)

6.2 North America COVID-19 Diagnostic Testing Revenue by Application (2016-2026)

6.3 North America COVID-19 Diagnostic Testing Market Size by Country

6.3.1 North America COVID-19 Diagnostic Testing Revenue by Country (2016-2026)

6.3.2 United States COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

6.3.3 Canada COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

6.3.4 Mexico COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe COVID-19 Diagnostic Testing Revenue by Type (2016-2026)

7.2 Europe COVID-19 Diagnostic Testing Revenue by Application (2016-2026)

7.3 Europe COVID-19 Diagnostic Testing Market Size by Country

7.3.1 Europe COVID-19 Diagnostic Testing Revenue by Country (2016-2026)

7.3.2 Germany COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.3 France COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.5 Russia COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

7.3.6 Italy COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific COVID-19 Diagnostic Testing Revenue by Type (2016-2026)

8.2 Asia-Pacific COVID-19 Diagnostic Testing Revenue by Application (2016-2026)

8.3 Asia-Pacific COVID-19 Diagnostic Testing Market Size by Region

8.3.1 Asia-Pacific COVID-19 Diagnostic Testing Revenue by Region (2016-2026)

8.3.2 China COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.3 Japan COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.4 South Korea COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.5 India COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

8.3.7 Australia COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America COVID-19 Diagnostic Testing Revenue by Type (2016-2026)

9.2 South America COVID-19 Diagnostic Testing Revenue by Application (2016-2026)

9.3 South America COVID-19 Diagnostic Testing Market Size by Country

9.3.1 South America COVID-19 Diagnostic Testing Revenue by Country (2016-2026)

9.3.2 Brazil COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

9.3.3 Argentina COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa COVID-19 Diagnostic Testing Revenue by Type (2016-2026)

10.2 Middle East & Africa COVID-19 Diagnostic Testing Revenue by Application (2016-2026)

10.3 Middle East & Africa COVID-19 Diagnostic Testing Market Size by Country

10.3.1 Middle East & Africa COVID-19 Diagnostic Testing Revenue by Country (2016-2026)

10.3.2 Turkey COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

10.3.4 UAE COVID-19 Diagnostic Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global COVID-19 Diagnostic Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global COVID-19 Diagnostic Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market COVID-19 Diagnostic Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global COVID-19 Diagnostic Testing Revenue (USD Million) by Region (2016-2021)

Table 5. Global COVID-19 Diagnostic Testing Revenue Market Share by Region (2021-2026)

Table 6. Cellex Corporate Information, Head Office, and Major Competitors

Table 7. Cellex Major Business

Table 8. Cellex COVID-19 Diagnostic Testing Product and Solutions

Table 9. Cellex COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Major Business

Table 12. Abbott COVID-19 Diagnostic Testing Product and Solutions

Table 13. Abbott COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Roche Corporate Information, Head Office, and Major Competitors

Table 15. Roche Major Business

Table 16. Roche COVID-19 Diagnostic Testing Product and Solutions

Table 17. Roche COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. BioMedomics Corporate Information, Head Office, and Major Competitors

Table 19. BioMedomics Major Business

Table 20. BioMedomics COVID-19 Diagnostic Testing Product and Solutions

Table 21. BioMedomics COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. BD Corporate Information, Head Office, and Major Competitors

Table 23. BD Major Business

Table 24. BD COVID-19 Diagnostic Testing Product and Solutions

Table 25. BD COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Henry Schein Corporate Information, Head Office, and Major Competitors

Table 27. Henry Schein Major Business

Table 28. Henry Schein COVID-19 Diagnostic Testing Product and Solutions

Table 29. Henry Schein COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Safecare Bio-Tech Corporate Information, Head Office, and Major Competitors

Table 31. Safecare Bio-Tech Major Business

Table 32. Safecare Bio-Tech COVID-19 Diagnostic Testing Product and Solutions

Table 33. Safecare Bio-Tech COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Mayo Clinic Laboratories Corporate Information, Head Office, and Major Competitors

Table 35. Mayo Clinic Laboratories Major Business

Table 36. Mayo Clinic Laboratories COVID-19 Diagnostic Testing Product and Solutions

Table 37. Mayo Clinic Laboratories COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Chembio Diagnostics Corporate Information, Head Office, and Major Competitors

Table 39. Chembio Diagnostics Major Business

Table 40. Chembio Diagnostics COVID-19 Diagnostic Testing Product and Solutions

Table 41. Chembio Diagnostics COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Mount Sinai Laboratory Corporate Information, Head Office, and Major Competitors

Table 43. Mount Sinai Laboratory Major Business

Table 44. Mount Sinai Laboratory COVID-19 Diagnostic Testing Product and Solutions

Table 45. Mount Sinai Laboratory COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors

Table 47. Ortho Clinical Diagnostics Major Business

Table 48. Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Product and Solutions

Table 49. Ortho Clinical Diagnostics COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Zhejiang Orient Gene Biotech Corporate Information, Head Office, and Major Competitors

Table 51. Zhejiang Orient Gene Biotech Major Business

Table 52. Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Product and Solutions

Table 53. Zhejiang Orient Gene Biotech COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Innovita Biological Technology Corporate Information, Head Office, and Major Competitors

Table 55. Innovita Biological Technology Major Business

Table 56. Innovita Biological Technology COVID-19 Diagnostic Testing Product and Solutions

Table 57. Innovita Biological Technology COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Guangzhou Wondfo Biotech Corporate Information, Head Office, and Major Competitors

Table 59. Guangzhou Wondfo Biotech Major Business

Table 60. Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Product and Solutions

Table 61. Guangzhou Wondfo Biotech COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Guangdong Hecin-Scientific Corporate Information, Head Office, and Major Competitors

Table 63. Guangdong Hecin-Scientific Major Business

Table 64. Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Product and Solutions

Table 65. Guangdong Hecin-Scientific COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Dynamiker Biotechnology (Tianjin) Corporate Information, Head Office, and Major Competitors

Table 67. Dynamiker Biotechnology (Tianjin) Major Business

Table 68. Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Product and Solutions

Table 69. Dynamiker Biotechnology (Tianjin) COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. ADVAITE Corporate Information, Head Office, and Major Competitors

Table 71. ADVAITE Major Business

Table 72. ADVAITE COVID-19 Diagnostic Testing Product and Solutions

Table 73. ADVAITE COVID-19 Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global COVID-19 Diagnostic Testing Revenue (USD Million) by Players (2019-2021)

Table 75. Global COVID-19 Diagnostic Testing Revenue Share by Players (2019-2021)

Table 76. Breakdown of COVID-19 Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. COVID-19 Diagnostic Testing Players Head Office, Products and Services Provided

Table 78. COVID-19 Diagnostic Testing Mergers & Acquisitions in the Past Five Years

Table 79. COVID-19 Diagnostic Testing New Entrants and Expansion Plans

Table 80. Global COVID-19 Diagnostic Testing Revenue (USD Million) by Type (2016-2021)

Table 81. Global COVID-19 Diagnostic Testing Revenue Share by Type (2016-2021)

Table 82. Global COVID-19 Diagnostic Testing Revenue Forecast by Type (2021-2026)

Table 83. Global COVID-19 Diagnostic Testing Revenue by Application (2016-2021)

Table 84. Global COVID-19 Diagnostic Testing Revenue Forecast by Application (2021-2026)

Table 85. North America COVID-19 Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 86. North America COVID-19 Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 87. North America COVID-19 Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 88. North America COVID-19 Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 89. North America COVID-19 Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 90. North America COVID-19 Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe COVID-19 Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe COVID-19 Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe COVID-19 Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe COVID-19 Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe COVID-19 Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe COVID-19 Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific COVID-19 Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific COVID-19 Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific COVID-19 Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific COVID-19 Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific COVID-19 Diagnostic Testing Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific COVID-19 Diagnostic Testing Revenue by Region (2021-2026) & (USD Million)

Table 103. South America COVID-19 Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 104. South America COVID-19 Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 105. South America COVID-19 Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 106. South America COVID-19 Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 107. South America COVID-19 Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 108. South America COVID-19 Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa COVID-19 Diagnostic Testing Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa COVID-19 Diagnostic Testing Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa COVID-19 Diagnostic Testing Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa COVID-19 Diagnostic Testing Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa COVID-19 Diagnostic Testing Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa COVID-19 Diagnostic Testing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. COVID-19 Diagnostic Testing Picture

Figure 2. Global COVID-19 Diagnostic Testing Revenue Market Share by Type in 2020

Figure 3. Nucleic Acid Testing

Figure 4. Antibody Testing

Figure 5. COVID-19 Diagnostic Testing Revenue Market Share by Application in 2020

Figure 6. Hospitals Picture

Figure 7. Scientific Research Picture

Figure 8. Global COVID-19 Diagnostic Testing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 9. Global COVID-19 Diagnostic Testing Revenue and Forecast (2016-2026) & (USD Million)

Figure 10. Global COVID-19 Diagnostic Testing Revenue Market Share by Region (2016-2026)

Figure 11. Global COVID-19 Diagnostic Testing Revenue Market Share by Region in 2020

Figure 12. North America COVID-19 Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 13. Europe COVID-19 Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Asia-Pacific COVID-19 Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. South America COVID-19 Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Middle East and Africa COVID-19 Diagnostic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. COVID-19 Diagnostic Testing Market Drivers

Figure 18. COVID-19 Diagnostic Testing Market Restraints

Figure 19. COVID-19 Diagnostic Testing Market Trends

Figure 20. Cellex Recent Developments and Future Plans

Figure 21. Abbott Recent Developments and Future Plans

Figure 22. Roche Recent Developments and Future Plans

Figure 23. BioMedomics Recent Developments and Future Plans

Figure 24. BD Recent Developments and Future Plans

Figure 25. Henry Schein Recent Developments and Future Plans

Figure 26. Safecare Bio-Tech Recent Developments and Future Plans

Figure 27. Mayo Clinic Laboratories Recent Developments and Future Plans

Figure 28. Chembio Diagnostics Recent Developments and Future Plans

Figure 29. Mount Sinai Laboratory Recent Developments and Future Plans

Figure 30. Ortho Clinical Diagnostics Recent Developments and Future Plans

Figure 31. Zhejiang Orient Gene Biotech Recent Developments and Future Plans

Figure 32. Innovita Biological Technology Recent Developments and Future Plans

Figure 33. Guangzhou Wondfo Biotech Recent Developments and Future Plans

Figure 34. Guangdong Hecin-Scientific Recent Developments and Future Plans

Figure 35. Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans

Figure 36. ADVAITE Recent Developments and Future Plans

Figure 37. Global COVID-19 Diagnostic Testing Revenue Share by Players in 2020

Figure 38. COVID-19 Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 39. Global Top 3 Players COVID-19 Diagnostic Testing Revenue Market Share in 2020

Figure 40. Global Top 10 Players COVID-19 Diagnostic Testing Revenue Market Share in 2020

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 42. Global COVID-19 Diagnostic Testing Revenue Share by Type in 2020

Figure 43. Global COVID-19 Diagnostic Testing Market Share Forecast by Type (2021-2026)

Figure 44. Global COVID-19 Diagnostic Testing Revenue Share by Application in 2020

Figure 45. Global COVID-19 Diagnostic Testing Market Share Forecast by Application (2021-2026)

Figure 46. North America COVID-19 Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 47. North America COVID-19 Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 48. North America COVID-19 Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 49. United States COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Canada COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Mexico COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Europe COVID-19 Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 53. Europe COVID-19 Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 54. Europe COVID-19 Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 55. Germany COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. France COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. United Kingdom COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Russia COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Italy COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Asia-Pacific COVID-19 Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 61. Asia-Pacific COVID-19 Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific COVID-19 Diagnostic Testing Revenue Market Share by Region (2016-2026)

Figure 63. China COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Japan COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South Korea COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. India COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Southeast Asia COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Australia COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South America COVID-19 Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 70. South America COVID-19 Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 71. South America COVID-19 Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 72. Brazil COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East and Africa COVID-19 Diagnostic Testing Sales Market Share by Type (2016-2026)

Figure 75. Middle East and Africa COVID-19 Diagnostic Testing Sales Market Share by Application (2016-2026)

Figure 76. Middle East and Africa COVID-19 Diagnostic Testing Revenue Market Share by Country (2016-2026)

Figure 77. Turkey COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Saudi Arabia COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. UAE COVID-19 Diagnostic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source